Swiss Pharma Nycomed Agrees To Market NPS’ Gattex Ex-U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
NPS gets $35 million upfront, potential $150 million in milestones and double-digit royalties from Nycomed for Gattex.